Patents by Inventor Benjamin G. Hoffstrom

Benjamin G. Hoffstrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-ROR1 antibodies and uses thereof
    Patent number: 11932691
    Abstract: The present disclosure relates to anti-ROR1 binding proteins, including those that bind to a ROR1 or portion thereof such as an intracellular C terminal portion of a ROR1 protein, and the use of such binding proteins in immunohistochemical and diagnostic methods. Related kits and methods of using the binding proteins are also provided, as are methods of treatment of subjects having diseases or conditions determined to be candidates for such treatments by the binding proteins or methods of this disclosure.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: March 19, 2024
    Assignee: Fred Hutchinson Cancer Center
    Inventors: Ashwini Balakrishnan, Benjamin G. Hoffstrom, Julie Randolph-Habecker, Stanley R. Riddell
  • ANTI-ROR1 ANTIBODIES AND USES THEREOF
    Publication number: 20210147540
    Abstract: The present disclosure relates to anti-ROR1 binding proteins, including those that bind to a ROR1 or portion thereof such as an intracellular C terminal portion of a ROR1 protein, and the use of such binding proteins in immunohistochemical and diagnostic methods. Related kits and methods of using the binding proteins are also provided, as are methods of treatment of subjects having diseases or conditions determined to be candidates for such treatments by the binding proteins or methods of this disclosure.
    Type: Application
    Filed: January 25, 2021
    Publication date: May 20, 2021
    Inventors: Ashwini Balakrishnan, Benjamin G. Hoffstrom, Julie Randolph-Habecker, Stanley R. Riddell
  • Anti-ROR1 antibodies and uses thereof
    Patent number: 10968275
    Abstract: The present disclosure relates to anti-ROR1 binding proteins, including those that bind to a ROR1 or portion thereof such as an intracellular C terminal portion of a ROR1 protein, and the use of such binding proteins in immunohistochemical and diagnostic methods. Related kits and methods of using the binding proteins are also provided, as are methods of treatment of subjects having diseases or conditions determined to be candidates for such treatments by the binding proteins or methods of this disclosure.
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: April 6, 2021
    Assignee: FRED HUTCHINSON CANCER RESEARCH CENTER
    Inventors: Ashwini Balakrishnan, Benjamin G. Hoffstrom, Julie Randolph-Habecker, Stanley R. Riddell
  • Anti-ROR1 antibodies and uses thereof
    Patent number: 10927174
    Abstract: The present disclosure relates to anti-ROR1 binding proteins, including those that bind to a ROR1 or portion thereof such as an intracellular C terminal portion of a ROR1 protein, and the use of such binding proteins in immunohistochemical and diagnostic methods. Related kits and methods of using the binding proteins are also provided, as are methods of treatment of subjects having diseases or conditions determined to be candidates for such treatments by the binding proteins or methods of this disclosure.
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: February 23, 2021
    Assignee: FRED HUTCHINSON CANCER RESEARCH CENTER
    Inventors: Ashwini Balakrishnan, Benjamin G. Hoffstrom, Julie Randolph-Habecker, Stanley R. Riddell
  • ANTI-ROR1 ANTIBODIES AND USES THEREOF
    Publication number: 20190040132
    Abstract: The present disclosure relates to anti-ROR1 binding proteins, including those that bind to a ROR1 or portion thereof such as an intracellular C terminal portion of a ROR1 protein, and the use of such binding proteins in immunohistochemical and diagnostic methods. Related kits and methods of using the binding proteins are also provided, as are methods of treatment of subjects having diseases or conditions determined to be candidates for such treatments by the binding proteins or methods of this disclosure.
    Type: Application
    Filed: February 2, 2017
    Publication date: February 7, 2019
    Inventors: Ashwini Balakrishnan, Benjamin G. Hoffstrom, Julie Randolph-Habecker, Stanley R. Riddell
  • COMPOSITIONS AND METHODS FOR TREATMENT OF FILOVIRUS-MEDIATED DISEASES
    Publication number: 20130289024
    Abstract: The invention features compositions, methods, and kits useful for the treatment of filovirus-mediated diseases, e.g., hemorrhagic fever caused by Ebola virus, in an animal.
    Type: Application
    Filed: June 27, 2013
    Publication date: October 31, 2013
    Inventors: Lisa M. JOHANSEN, Joseph LEHÁR, Benjamin G. HOFFSTROM, Gene G. OLINGER, Andrea R. STOSSEL
  • Compositions and methods for treatment of filovirus-mediated diseases
    Patent number: 8475804
    Abstract: The invention features compositions, methods, and kits useful for the treatment of filovirus-mediated diseases, e.g., hemorrhagic fever caused by Ebola virus, in an animal.
    Type: Grant
    Filed: February 22, 2010
    Date of Patent: July 2, 2013
    Assignees: U.S. Army Medical Research and Material Command, Zalicus, Inc.
    Inventors: Lisa M. Johansen, Joseph Lehár, Benjamin G. Hoffstrom, Gene G. Olinger, Andrea R. Stossel
  • COMPOSITIONS AND METHODS FOR TREATMENT OF FILOVIRUS-MEDIATED DISEASES
    Publication number: 20110028564
    Abstract: The invention features compositions, methods, and kits useful for the treatment of filovirus-mediated diseases, e.g., hemorrhagic fever caused by Ebola virus, in an animal.
    Type: Application
    Filed: February 22, 2010
    Publication date: February 3, 2011
    Inventors: Lisa M. Johansen, Joseph Lehár, Benjamin G. Hoffstrom, Gene G. Olinger, Andrea R. Stossel